Compare stocks

Medacta Group SA is a Swiss-based company specializing in the design, production, and distribution of orthopedic medical devices. The company's core business focuses on hip and knee replacement products, as well as spine surgery and sports medicine solutions. Founded in 1999, Medacta is headquartered in Castel San Pietro, Switzerland. The company distinguishes itself through its commitment to medical education, providing training and resources to healthcare professionals to enhance surgical outcomes. Medacta also emphasizes innovation in minimally invasive surgical techniques and personalized solutions to improve patient care and recovery times.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.